Shl Telemedicine Ltd. · SIX:SHLTN
Shl Telemedicine — FY2021 Earnings Presentation
14 slides from Shl Telemedicine's earnings presentation, April 2022
Slide 1: SHL Telemedicine FY Results 2021 Presentation
SHL Telemedicine FY Results 2021 Presentation April 2022
Slide 2: Forward looking statements
Forward looking statements This presentation contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or ac
Slide 3: SHL Telemedicine at a Glance
SHL Telemedicine at a Glance SHL is a leading Swiss Stock Exchange Telemedicine Provide 24/7 telehealth provider and developer (Symbol: SHLTN) centers in Israel and monitoring with global of advanced telehealth Mkt cap ~$280m Germany with service capabilities technology and services Nasdaq Listing p
Slide 4: SHL accelerates its global telemedicine operations for rapid implementation of proven technologies and services
SHL accelerates its global telemedicine operations for rapid implementation of proven technologies and services Use of A.I. Technology (Artificial-Intelligence) Use of large databases (Big-Data) Collaboration with leading strategic healthcare industry partners Realization of growth potential in exis
Slide 5: 2021 – Turning Point Year
2021 – Turning Point Year Israel Germany USA • Increase of about 30% in revenues • Stable revenues in Germany of about $18 • Substantial agreements with leading following the merger of Mediton Group million FORTUNE 500 entities such as CVS – CTS in the last part of the year • New multi-year contract
Slide 6: Israel – ~30% increase in turnover
Israel – ~30% increase in turnover B2C model - sale of cardiac monitoring services to consumers: personal 12 Lead ECG devices for transmission of remote medical data, 24/7 telemedicine center, electronic personal medical record, Mobile Intensive Care Units in coverage areas • About 50,000 subscriber
Slide 7: Germany – Significant growth expected in the coming years
Germany – Significant growth expected in the coming years • SHL is the market leader in Germany operating a B2B model - monitors and stabilizes chronic patients and saves costs for the Sick Funds • The Company has agreements with leading Sick Funds covering about 30% of the German health insurance m
Slide 8: USA – Faster than planned progress
USA – Faster than planned progress Collaboration with leading healthcare industry partners ✓ Commercial agreement to expand use of SmartHeart across different platforms at MAYO CLINIC Hospitals, Home Health, Nursing Homes ❖ Deployment of SmartHart ECG technology ✓ Over 6,000 hospitals and 11,300 Hom
Slide 9: A.I. ECG Tools
A.I. to exponentially increase demand and use of SmartHeartTM full 12-lead ECG A.I. ECG Tools HOSPITALS CONSUMERS PAYORS – RETAIL Value Base CHAINS Care Cloud based ECG repository Home WALK IN Health – RETAIL Post Acute CLINICS PHARMA - CRO PRACTICES ➢ 24/7 ECG review ➢ Provider Portal
Slide 10: Financials – P&L
Financials – P&L Revenue 60,000 50,000 In USD million 40,000 (except per share amount) FY 2021 FY 2020 FY 2020 cc(*) 30,000 20,000 Revenue for the period 49.6 40.2 42.3 10,000 Revenue by territories - 2020 2021 Germany 17.9 17.0 17.7 EBIDA Israel 31.2 22.5 24.0 6,000 Others 0.4 0.6 0.6 5,000 4,000 A
Slide 11: Financials - Balance Sheet and Cash Flow
Financials - Balance Sheet and Cash Flow In USD million FY 2021 FY 2020 Cash and cash equivalents 14.8 4.1 Short term bank investments 17.2 6.5 Total Assets (in million) Total cash and short term investments 32.0 10.6 140 120 Short term bank debt 1.8 2.3 100 Long term bank debts 17.2 80 Total debts
Slide 12: Senior Management
Senior Management Recruitment of President / General Manager SHL USA – in process Yossi Vadnagra Linus Drop Amir Hai Yariv Alroy Erez Nachtomy General Manager Managing Director CFO CEO Chairman of the Board SHL Israel SHL Germany
Slide 13: 2022 – Expected events
2022 – Expected events • Nasdaq Listing • Expansion of US activity • Recruiting of US CEO • Expansion of Doctor’s Virtual Visits activity in Germany • Additional agreements from existing strategic channels in the US • Additional agreements for monitoring patients in Germany
Slide 14: Thank you
Thank you